Login to Your Account

Washington Roundup

Wednesday, June 19, 2013

The FDA is investigating two unexplained deaths in patients who received an intramuscular injection of Indianapolis-based Eli Lilly and Co.'s antipsychotic drug Zyprexa Relprevv (olanzapine pamoate).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription